Skip to main content
. Author manuscript; available in PMC: 2013 May 7.
Published in final edited form as: J Pediatr Endocrinol Metab. 2011;24(0):683–687. doi: 10.1515/jpem.2011.322

Table 2.

Hormonal and metabolic characteristics of the study populationa

PA (n=24) Control (n=25) P valueb
Retinol-binding protein 4 (mg/L) 16.7 ± 6.4 14.3 ± 5.5 NS
Testosterone (ng/dL) 6.0 ± 2.7 3.5 ± 0.8 0.0003
Free Testosterone (pg/mL) 0.48 ± 0.27 0.30 ± 0.18 0.0003
DHEAS (ug/dL) 53.4 ± 42.1 22.1 ± 18.9 0.002
SHBG (nmol/L) 89.1 ± 32.5 105.3 ± 52.0 0.02
Androstenedione (ng/dL) 46.2 ± 16.5 29.4 ± 7.3 <0.0001
Cholesterol (mg/dL) 161.0 ± 26.4 164.0 ± 32.0 NS
Triglycerides (mg/dL) 72.0 ± 26.2 77.9 ± 40.0 NS
LDL (mg/dL) 90.3 ± 23.6 97.0 ± 32.6 NS
HDL (mg/dL) 56.3 ± 9.7 51.6 ± 12.1 NS
Glucose (mg/dL, 0 min) 88.8 ± 7.0 90.1 ± 7.8 NS
Glucose (mg/dL, AUC) 233.5 ± 45.1 221.4 ± 51.1 NS
Insulin (uU/mL, 0 min) 7.2 ± 6.2 5.7 ± 2.8 NS
Insulin (uU/mL, AUC) 71.6 ± 38.3 54.3 ± 37.8 0.02
FGIR 21.7 ± 17.1 21.7 ± 17.9 NS
HOMA 1.3 ± 0.7 1.6 ± 1.4 NS
SiM 10.0 ± 11.1 13.7 ± 14.4 0.002
WBISI 10.4 ± 6.3 11.1 ± 7.6 0.04
a

Results are expressed as mean ± SD;

b

BMI Z-score adjusted analysis. AUC, area under the curve; NS, not significant